India: +91-80-65333444 | Singapore: +65-31631880
  U.S / Canada Toll Free: +1-866-259-4781
  Kenya: +254-732-300719

          

Clinical Trial News

Type 2 diabetes: Blood sugar pill shows promise

In a 26-week phase II clinical trial for type 2 diabetes patients, glycemic control using semaglutide in pill form was better than using a placebo.

Cannabis intoxication may be stopped with anti-obesity drug

Intoxication with so-called legal highs may be fatal. But new research may have found the antidote in a slimming drug that blocks cannabinoid receptors.

Heart failure could be treated using umbilical cord stem cells

In the first study of its kind, researchers find that stem cells derived from the umbilical cord can be used to treat heart failure.

Poliovirus kills off cancer cells, stops tumor regrowth

A modified poliovirus appears to trigger the body's anti-tumor immunity. The new study showed promising results in human breast cancer cells and mice.

Drug resistance: WHO report 'serious lack of new antibiotics'

A new report from the WHO reveals that the current scope of new antibiotic development is far from what is needed to tackle drug resistance.

Sugarcane extract may relieve stress-induced insomnia

Researchers find that octacosanol - a compound found in sugarcane, beeswax, and wheat germ oil - can restore stress-affected sleep in mice.

Reducing inflammation without lowering cholesterol cuts risk of cardiovascular events

Inflammatory hypothesis confirmed: Landmark randomized clinical trial of high-risk patients finds that a drug targeting inflammation reduced risk of major adverse cardiovascular events.

Multiple sclerosis: Are we close to a cure?

Discoveries and breakthroughs in multiple sclerosis research are building momentum, but just how close are we to finding a cure? We investigate.



James Lind Institute Newsletter
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Email Update
James Lind Institute Blog
James Lind Institute Facebook